Jazz Pharmaceuticals Public Limited CompanyStock Price and Value Analysis

Should you buy Jazz Pharmaceuticals Public Limited Company stock? (NasdaqGS:JAZZ). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company is solid.
  • This stock looks overpriced.
  • This company is not making money.
  • This company has wild ups and downs.
  • This company pays no dividend.

JAZZ Free Cash Flow Trend

Hmm, we can't give any reliable projection for Jazz Pharmaceuticals Public Limited Company's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for JAZZ
Free Cash Flow trendline for Jazz Pharmaceuticals Public Limited Company

Inside the JAZZ Numbers

JAZZ Price
(Jazz Pharmaceuticals Public Limited Company stock price per share)
$135.50
[?] PE Ratio versus Sector 2% higher than other Healthcare stocks
[?] PE Ratio versus Industry 63% lower than other Biotechnology stocks
[?] Cash Yield 6.11%
[?] Free Cash Flow Jitter 77%

Is Jazz Pharmaceuticals Public Limited Company Stock on Sale?

Based on our analysis, we believe that you should not buy Jazz Pharmaceuticals Public Limited Company right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy JAZZ Stock?

Does Jazz Pharmaceuticals Public Limited Company have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.